Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy

By Voltolini L.   Luzzi L.   Ghiribelli C.   Paladini P.   Di Bisceglie M.   Gotti G.  

European Journal of Cardio-Thoracic Surgery, Vol. 20, Iss. 6, 2001-12 ,pp. : 1106-1112

Elsevier

Access to resources Recommend Favorite

Time trends and survival after surgery for p-stage IIIa, pN2 non-small cell lung cancer (NSCLC)

By Tanaka F.   Yanagihara K.   Ohtake Y.   Fukuse T.   Hitomi S.   Wada H.  

European Journal of Cardio-Thoracic Surgery, Vol. 12, Iss. 3, 1997-09 ,pp. : 372-379

Elsevier

Access to resources Recommend Favorite

Advantage of post-operative oral administration of UFT (Tegafur and Uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC)

By Tanaka F.   Miyahara R.   Ohtake Y.   Yanagihara K.   Fukuse T.   Hitomi S.   Wada H.  

European Journal of Cardio-Thoracic Surgery, Vol. 14, Iss. 3, 1998-09 ,pp. : 256-262

Elsevier

Access to resources Recommend Favorite

Advantage of postoperative oral administration of UFT (Tegafur and Uracil) for completely resected p-Stage I-IIIa non-small cell lung cancer (NSCLC)

By Maggi G.   Ruffini E.  

European Journal of Cardio-Thoracic Surgery, Vol. 14, Iss. 3, 1998-09 ,pp. : 263-264

Elsevier

Access to resources Recommend Favorite

Recurrence-free survival and prognostic factors in resected pN2 non-small cell lung cancer

By Choi Y.S.   Shim Y.M.   Kim J.   Kim K.  

European Journal of Cardio-Thoracic Surgery, Vol. 22, Iss. 5, 2002-11 ,pp. : 695-700

Elsevier

Access to resources Recommend Favorite